Christopher Posner
President and CEO at Tvardi Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Tvardi Therapeutics Inc., 3 years.
Tvardi Therapeutics Inc.
Director · PRESIDENT AND CEO
Chief executive roles
Tvardi Therapeutics Inc.
· President and CEO
Until April 2025
· Former
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 28, 2025 | Tvardi Therapeutics Inc. | Open-market sale | −583 | $4.75 | $2,769 |
| Feb 4, 2025 | Tvardi Therapeutics Inc. | Open-market sale | −372 | $4.72 | $1,756 |
| Nov 4, 2024 | Tvardi Therapeutics Inc. | Open-market sale | −3,668 | $0.29 | $1,064 |
| Aug 1, 2024 | Tvardi Therapeutics Inc. | Open-market sale | −4,149 | $0.35 | $1,452 |
| May 2, 2024 | Tvardi Therapeutics Inc. | Open-market sale | −3,936 | $0.75 | $2,952 |
| Feb 29, 2024 | Tvardi Therapeutics Inc. | Open-market sale | −5,834 | $0.89 | $5,192 |
| Feb 8, 2024 | Tvardi Therapeutics Inc. | Open-market sale | −35,575 | $0.53 | $18,855 |
| Feb 1, 2024 | Tvardi Therapeutics Inc. | Grant or award | +62,500 | — | — |
| Feb 1, 2024 | Tvardi Therapeutics Inc. | Open-market sale | −4,981 | $0.55 | $2,740 |
| Nov 2, 2023 | Tvardi Therapeutics Inc. | Open-market sale | −3,796 | $1.22 | $4,631 |
| Aug 3, 2023 | Tvardi Therapeutics Inc. | Open-market sale | −4,307 | $3.07 | $13,222 |
| May 5, 2023 | Tvardi Therapeutics Inc. | Open-market sale | −3,869 | $4.40 | $17,024 |
| Mar 3, 2023 | Tvardi Therapeutics Inc. | Open-market sale | −5,987 | $9.71 | $58,134 |
| Feb 2, 2023 | Tvardi Therapeutics Inc. | Open-market sale | −4,191 | $11.80 | $49,454 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.